top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us
.

Medicines Management Board Minutes

The Medicines Management Board meet on a monthly basis to discuss and make decisions on new medicines and policies. 

 

The upcoming dates for 2013/2014 are: 

  

  • Wednesday, September 18th                    

  • Wednesday, October 16th               

  • Wednesday, November 20th                       

  • Wednesday, December 18th

  • Wednesday 15th Jan 2014

  • Wednesday 19th Feb 2014

  • Wednesday 19th Mar 2014

  • Wednesday 16th April 2014

  • Wednesday 21st May 2014

  • Wednesday 18th June 2014

  • Wednesday 16th July 2014

  • Wednesday 20th Aug 2014

  • Wednesday 17th Sept 2014

  • Wednesday 15th Oct 2014

  • Wednesday 19th Nov 2014

  • Wednesday 17th Dec 2014

 

Below you will find the minutes from each of the meetings from January 2010 onwards. The minutes from subsequent meetings will be added as soon as they become available. 

 

Current Year - Medicines Management Board Minutes

 TitleCreatedDownload
application/pdfMedicine Management Board Minutes 21st May 2014 (179 KB)31/07/2014Download
 NOAC's position Statement - The position statement with a preferred option NOAC will not be pursued and all three will be available for prescribing, with traffic light remaining Amber. NEW PRODUCT REQUESTS – CARBETOCIN and AZARGA EYE DROPS- deferred  
application/pdfMedicines Management Board Minutes 18.06.2014 (183 KB)31/07/2014Download
 NEW PRODUCT REQUESTS – CARBETOCIN - formulary for use following elective caesarean section Traffic Light: RED AZARGA EYE DROPS - second line when dorzolamide/timolol combination is not tolerated - Traffic Light: GREEN  
application/pdfMedicines Management Board Minutes 16th April 2014 (226 KB)12/06/2014Download
 New Product Requests -Glycopyrronium for hyperhidrosis. Denosumab in prostate cancer. Hyoscine, melatonin Shared Care Protocol. NOAC's position Statement for East Lancashire Health Economy . New Product Request – Ostenil Plus. Erectile Dysfunction Guidelines. Blood Glucose Testing devices for Paediatrics. Unlicensed Request –Testosterone Gel, ELHT – JOINT CATHETER CARE FORMULARY. NEW PRODUCT REQUEST – BROMFENAC EYE DROPS. Denosumab Shared Care Guidelines. Strontium Ranelate. Indapamide, NICE REC 
application/pdfMedicines Management Board Minutes 19th March 2014 (183 KB)06/05/2014Download
 Xiapex Policy and Form updated. ELHT bowel prepartion PIL finalised. ELHT Fosfomycin for UTI protocol - joint letter to be sent to GPs. New product Request - Ostenil Plus - rejected. ED Guidelines completed. Unlicensed Request - Pilocarpine for dry mouth on specialist palliative care initiation - AMBER traffic light. ELHT medicines policy updated and acknowledged by ELMMB. Dapoxetine - was BLACK traffic light now Grey Under Review. Fluarix Tetra - Grey under review awaiting guidance from N 
application/pdfMedicines Management Board Minutes February 2014 (196 KB)25/03/2014Download
  
application/pdfMedicines Management Board Minutes January 2014 (189 KB)25/03/2014Download
  
application/pdfMedicines Management Board Minutes ELHE December 2013 (277 KB)29/01/2014Download
 New Product Requests: Rotigotine - not recommended for restless leg syndrome. To be considered as part of a review guideline - BLACK Traffic Light. Flutiform - not recommended for asthma. To be considered as part of asthma guideline - BLACk Traffic Light. LMMG Recommendations - Taurine inf CF Liver Disease - BLACK Traffic Light. Guidelines for Good Prescribing in Primnary care - updated ELHE guideline for use in Lancashire - accepted for ELHE as written. Prescribing Guidleines for NOACs in A 
application/pdfMedicines Management Board Minutes 20th November 2013 (193 KB)06/01/2014Download
 New Product Requests -Epiduo Gel® - for 1st line treatment of acne vulgaris - Green traffic light. Melatonin for critical care - mangement of sleep impairment in critcalkly unwell patients - Red Traffic Light. Formulary updates: ingenol mebuate (Picato®)- GREEN traffic light, Fluorouracil+salicylic acid (Actikerall®) and imiquimod 3.75% (Zyclara®) - BLACK traffic light. Oxcarbazepine (Trileptal®) for use as monotherapy or adjunctive therapy in partial epilepsy only when carbamazepine, lamot 
application/pdfMedicines Management Board Minutes September 2013 (195 KB)03/12/2013Download
  
application/pdfMedicines Management Board Minutes July 2013 (208 KB)30/09/2013Download
 Oxetacaine with Antacid Susp - approved for use in palliative Care - RED traffic light Latanoprost Unit Dose Eye Drops - 2nd line when preservative free treatment reuired- Amber traffic Light Chlorhexidine eye drops - Opthalmology prescribing only for treatment of acanthamoeba keratitis - RED traffic light Aclidinium (Eklira Genuair®) - maintenance treatment of COPD - use restricted to patients who have not tolerated tiotropium, who after training are unable to use the tiotropium inhaler or  
application/pdfMedicines Management Board Minutes 19th June 2013 (189 KB)01/08/2013Download
 New product requests - Salbutamol easyhaler -green traffic light: Aquamax - rejected: Competact - Black traffic light. Formulary review - HuxD3 - green traffic light: Metoprolol - green traffic light: Qvar Easibreathe - green traffic light. Good practice guidelines for care homes - creams and expiry dates - approved. Nice Recommendations - Ranibizumab (NICE TA283) Red traffic light - as an option for treating visual impairment caused ny macular-oedema secondary to retina vein occlusion. Beva 
application/pdfMedicines Management Board Minutes 22nd May 2013 (216 KB)08/07/2013Download
 New product request - botulinum for anal fissure - BLACK traffic light. Unlicensed requests - Tiopronin for recurrent stones RED traffic light. Cantharidrin - deramatolgy use for recalcitrant warts - RED traffic light. Bupivacaine nebulised for chronic cough - specialist supervision - REC traffic light. Aripiprazole - for alternating hemiplegia under specialist supervision - RED traffic light. Sulthiame - for refractory epilepsy under specialist supervision - RED traffic light. NICE recommendat 
Page: [1] [2] [3] [4]
[ Next » ]

Archived Medicine Management Board Meeting Minutes

 TitleCreatedDownload
application/pdfMedicines Management Board Meeting 21st January 2010 (43 KB)19/07/2010Download
  
application/pdfMedicines Management Board Meeting 25th February 2010 (43 KB)19/07/2010Download
  
application/pdfMedicines Management Board Meeting 25th March 2010 (37 KB)19/07/2010Download
  
application/pdfMedicines Management Board Meeting 22nd April 2010 (44 KB)19/07/2010Download
 ** Vitamin D; Immunoglobulin; Oxycodone; Dementia; Hyaluronic Acid; Venlafaxine MR; Ranolazine; Aliskeren; pain releif protocol for patients dependent on opiates; Magnesium aspartate; Mesalazine preparations; Pramipexole MR;  
application/pdfMedicines Management Board Meeting 20th May 2010 (83 KB)19/07/2010Download
 ** Immunoglobulin; Oxycodone; Dementia; Hyaluronic Acid; Venlafaxine MR; Ranolazine; Aliskeren; Pain releief protocol for patients dependent on opiates; Vitamin D; PbR exclusions list; good prescribing guidelines; Clopidogrel & PPI; CAMET recommendations; Neuropathic Pain; Genotropin; Omnitrope; Anti-TNF; CQUIN; Specials; Tenofovir; Betesil;  
application/pdfMedicines Management Board Meeting 17th June 2010 (43 KB)19/07/2010Download
 ** Immunoglobulin; Oxycodone; Dementia; Hyaluronic Acid; Venlafaxine MR; Ranolazine; Aliskeren; Pain releif protocol for patients dependent on opioids; Magnesium aspartate; Vitamin D; Pramipexole MR; Good prescribing guidelines; Clopidogrel and PPI; Neuropathic Pain; Anti-TNF; Palliative Care Guidelines; Priority setting of medicines; Silver dressings; Sorafenib; Pemetrexed; Glucosamine; Neonatal Medicines formulary; Sugammadex; Transvasin Cream; Continence formulary;  
application/pdfMedicines Management Board Meeting 15th July 2010 (43 KB)31/08/2010Download
 ** Rituximab; Oxycodone; Dementia; Hyaluronic acid; Venlafaxine MR; Ranolazine; Aliskeren; Viatmin D guidelines; Pramipexole MR; Good prescribing guidelines; Neuropathic Pain; Continence and catheter care formulary; High priority medicines for monitoring; Prucalopride; Phenobarbitone liquid; Chloral Hydrate; Vigabatrin; Potassium canrenoate; Chlorthiazide liquid; Spironolactone liquid; Tobramycin injection; Lercanidipine, Colecalciferol Dekristol; Metformin SR; Quixil Evicel; NPSA LMWH; Red traf 
application/pdfMedicines Management Board Meeting 19th August 2010 (41 KB)11/10/2010Download
 ** Oxycodone; Dementia; Hyaluronic acid; Venlafaxine MR; Aliskeren; Ranolazine; Magnesium Aspartate; Good prescribing guidelines; Priority setting of medicines; Saxagliptin; Sativex; Amifampridine Firdapse; Dutasteride; Diabetes sub-cut insulin chart; Erectile dysfunction policy; MERLOT trial; Nebusal; 
application/pdfMedicines Management Board Meeting 16th September 2010 (38 KB)11/10/2010Download
 ** Oxycodone; Dementia; Hyaluronis Acid; Priority setting of medicines; Saxagliptin; Nebusal; Withdrawal of Mixtard; Lipid modification; Goserelin; MMB governance controls; Prescribing accuracy; Contraception formulary; Roflumilast & Indacaterol; Arthrotec; Simvastatin Liquid; Secretin; Good prescribing guidelines; Abatacept; Tocilizumab; Dronedarone; 
application/pdfMedicines Management Board Meeting 20th October 2010 (38 KB)06/12/2010Download
 ** Mixtard withdrawal; Oxycodone; Demetia; Hyaluronic Acid; Priority setting of medicines; Anti-TNF's; Wound care formulary; Opioid choice for syringe driver; Cancer drugs fund; Lithium; Modafinil; Implanon; Nexplanon;  
application/pdfMedicines Management Board Meeting 17th November 2010 (46 KB)21/04/2011Download
 ** Modafinil; Oxycodone; Dementia treated with antipsychotics; Hyaluronic Acid; MMB governance controls; COPD guidelines; Atimos Modulite; Ranolazine; Aliskeren; Anti-TNF; Saxagliptin; Prescribing Accuracy; Specials; Ulipristal Ellaone; Co-careldopa gel; Teriparetide; Paediatric specials; Prednisolone EC 5mg tablets; Potassium permanganate; Movelat; Algesal; Eltrombopag; Ofatamumab; Bendamustine; Temsirolimus; Denosumab; Midwifery prescribing and exemption; Bowel preparations; 
application/pdfMedicines Management Board Meeting 15th December 2010 (40 KB)21/04/2011Download
 ** Aliskeren; oxycodone; Demetia treated with antipsychotics; MMB governance controls; Ranolazine; Anti-TNF; NICE MM Sub group; Midwives exemptions; Paediatric specials; Tobramycin Bramitob; Omalizumab; Mycophenolate; Adrenaline autopen Jext; Premarin; Ovestin; Topical NSAIDS; Black light medicines; Bowel Preparations; Food First;  
All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.  

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.

Email: Interface@bwd.nhs.uk

Powered by EasySite™ Content Management System